Background Primary progressive multiple sclerosis (PPMS) is characterized by development
of more chronic neurological manifestations from disease onset compared with relapsing …

Background: In order to estimate the value of interventions in multiple sclerosis (MS)–where
lifetime costs and outcomes cannot be observed–outcome data have to be combined with …

Purpose A retrospective analysis of real-world data was performed to assess the
epidemiology and economic burden of multiple sclerosis (MS), relapsing-remitting MS …

Background Little is known of how the cost of illness and health-related quality of life
changes over time after a diagnosis of multiple sclerosis. Objectives The aim was thus to …

Introduction: In order to estimate the value of interventions in multiple sclerosis (MS)–where
lifetime costs and outcomes cannot be observed–outcome data have to be combined with …

Background: Little information on costs and quality of life (QoL) of patients with Multiple
Sclerosis (MS) has been published for Greece so far. Objective: The objective of the study …

Objectives Comprehensive economic costs of multiple sclerosis (MS) according to EDSS
states can only be assessed by evaluating MS management in real clinical practice. The …

Epidemiological data on primary progressive multiple sclerosis (PPMS) are scarce. This
study was aimed to evaluate the burden of PPMS in Italy with healthcare resources …

Introduction: To estimate the value of interventions in multiple sclerosis (MS)–where lifetime
costs and outcomes cannot be observed–outcome data have to be combined with costs …

Background Multiple sclerosis (MS) is a disease with profound heterogeneity in clinical
course. Objective To analyze sources and levels of income among MS patients in relation to …